https://www.med-guidelines.org.uk/index.php?action=history&feed=atom&title=Retinoic_Acid_Derivatives 2026-05-04T20:06:23Z Revision history for this page on the wiki MediaWiki 1.34.1 https://www.med-guidelines.org.uk/index.php?title=Retinoic_Acid_Derivatives&diff=2327&oldid=prev 2025-09-04T15:34:44Z

<p><span dir="auto"><span class="autocomment">Guidance</span></span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 15:34, 4 September 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l14" >Line 14:</td> <td colspan="2" class="diff-lineno">Line 14:</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Guidance==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Guidance==</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Generally unacceptable if ever taken Etretinate (Tigason)<del class="diffchange diffchange-inline">. Donors having taken, or currently taking, acitretin (Neotigason) or Isotretinoin (Roaccutane) may join the register</del>.</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Generally unacceptable if ever taken Etretinate (Tigason).  </div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>At <del class="diffchange diffchange-inline">CT</del>, inform <del class="diffchange diffchange-inline">the </del>transplant centre if a donor is taking these medications, or has done so at any point in the last 12 months.</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">Acceptable:</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">Donors having taken, or currently taking, acitretin (Neotigason) or Isotretinoin (Roaccutane) may join the register.</ins></div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr> <tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">*</ins>At <ins class="diffchange diffchange-inline">VT/Work up</ins>, <ins class="diffchange diffchange-inline">must </ins>inform transplant centre if a donor is taking <ins class="diffchange diffchange-inline">any of </ins>these medications, or has done so at any point in the last 12 months.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Pseudonyms or Related Conditions==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Pseudonyms or Related Conditions==</div></td></tr> <!-- diff cache key localdb-mw_:diff::1.12:old-1082:rev-2327 --> </table>

Ellouise.Bishop@anthonynolan.org https://www.med-guidelines.org.uk/index.php?title=Retinoic_Acid_Derivatives&diff=1082&oldid=prev 2013-05-02T16:59:38Z

<p><span dir="auto"><span class="autocomment">Guidance: </span> updated to be more permissive</span></p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 16:59, 2 May 2013</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l14" >Line 14:</td> <td colspan="2" class="diff-lineno">Line 14:</td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Guidance==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Guidance==</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Generally unacceptable if ever taken Etretinate (Tigason). <del class="diffchange diffchange-inline">Allow 12 months after </del>taking acitretin (Neotigason) <del class="diffchange diffchange-inline">and 4 weeks after </del>Isotretinoin (Roaccutane).</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Generally unacceptable if ever taken Etretinate (Tigason). <ins class="diffchange diffchange-inline">Donors having taken, or currently </ins>taking<ins class="diffchange diffchange-inline">, </ins>acitretin (Neotigason) <ins class="diffchange diffchange-inline">or </ins>Isotretinoin (Roaccutane) <ins class="diffchange diffchange-inline">may join the register</ins>.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">However</del>, these <del class="diffchange diffchange-inline">time periods may be shortened </del>at the <del class="diffchange diffchange-inline">discretion of the transplant centre</del>.</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">At CT</ins>, <ins class="diffchange diffchange-inline">inform the transplant centre if a donor is taking </ins>these <ins class="diffchange diffchange-inline">medications, or has done so </ins>at <ins class="diffchange diffchange-inline">any point in </ins>the <ins class="diffchange diffchange-inline">last 12 months</ins>.</div></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Pseudonyms or Related Conditions==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Pseudonyms or Related Conditions==</div></td></tr> <!-- diff cache key localdb-mw_:diff::1.12:old-908:rev-1082 --> </table>

Dr Robert Lown https://www.med-guidelines.org.uk/index.php?title=Retinoic_Acid_Derivatives&diff=908&oldid=prev 2012-06-19T13:22:53Z

<p>Protected &quot;<a href="/Retinoic_Acid_Derivatives" title="Retinoic Acid Derivatives">Retinoic Acid Derivatives</a>&quot; (‎[edit=sysop] (indefinite) ‎[move=sysop] (indefinite))</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 13:22, 19 June 2012</td> </tr> <!-- diff cache key localdb-mw_:diff::1.12:old-475:rev-908 --> </table>

Dr Robert Lown https://www.med-guidelines.org.uk/index.php?title=Retinoic_Acid_Derivatives&diff=475&oldid=prev 2012-06-14T13:52:46Z

<p>Page created</p> <p><b>New page</b></p><div>==Acceptability at Recruitment==<br /> QUALIFIED<br /> <br /> ==Acceptability at CT / Work-Up==<br /> QUALIFIED<br /> <br /> ==Individual at Risk==<br /> Recipient<br /> <br /> ==Explanation of Condition==<br /> A group of drugs used to treat a number of inflammatory conditions, such as acne or psoriasis. <br /> <br /> However, they can cause severe congenital defects if given to pregnant women.<br /> <br /> ==Guidance==<br /> Generally unacceptable if ever taken Etretinate (Tigason). Allow 12 months after taking acitretin (Neotigason) and 4 weeks after Isotretinoin (Roaccutane).<br /> <br /> However, these time periods may be shortened at the discretion of the transplant centre.<br /> <br /> ==Pseudonyms or Related Conditions==<br /> <br /> <br /> ==Version==<br /> Version 1, Edition 1 <br /> <br /> ====Date of Last Update====<br /> 15th June 2012</div>

Dr Robert Lown